Fierce Biotech May 31, 2024
Trial software provider ConcertAI is partnering with Nvidia to develop new clinical simulations that inform future AI products for clinical trials, the company announced May 31 at the American Society of Cancer Oncology’s annual meeting.
“Nvidia Enterprise AI solutions are evolving faster than peers to provide the capability to rapidly build, deploy and manage custom generative AI and predictive AI models in both an efficient and scalable form,” Jeff Elton, Ph.D., CEO of ConcertAI, told Fierce Biotech in an email. “Our past body of work and new solutions now will leverage the Nvidia Enterprise AI capabilities to accelerate model development and deployment for the benefit of our customers and patients who depend on the precision and efficiencies offered by...
Today's Sponsors
Today's Sponsor